7-(AMINOETHYL) ETHER AND THIOETHER OF DAUNOMYCINONE

被引:15
作者
ACTON, EM
TONG, GL
MOSHER, CW
SMITH, TH
HENRY, DW
机构
[1] Bio-Organic Chemistry Laboratory, SRI International, Menlo Park
[2] Burroughs Wellcome Co., Research Triangle Park
关键词
D O I
10.1021/jm00194a007
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One-step treatment of daunomycinone with excess 2-aminoethanethiol and 2-aminoethanol in trifluoroacetic acid afforded at C-7 the thioether (77% yield) and ether (30% after recycling), respectively. Stereoselectivity for the natural IS over the 1R configuration was greater for the ether (97:3) than for the thioether (2.5:1). Esterification of daunomycin at C-7 with β-alanine was accomplished through the mixed anhydride of Z(OMe)-β-alanine. Preliminary biological tests suggest that the antitumor and DNA interactive properties of the anthracyclines can be retained in such structures. © 1979, American Chemical Society. All rights reserved.
引用
收藏
页码:922 / 926
页数:5
相关论文
共 18 条
[1]   DAUNOMYCIN .I. STRUCTURE OF DAUNOMYCINONE [J].
ARCAMONE, F ;
BARBIERI, W ;
FRANCESC.G ;
MONDELLI, R ;
OREZZI, P ;
CASSINELLI, G .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (23) :5334-&
[2]  
BACHUR NR, 1978, CANCER RES, V38, P1745
[3]  
BACHUR NR, 1976, ACS SYM SER, P58
[4]   CHEMICAL STUDIES ON LICHENS .34. SYNTHESIS OF CYCLO-(R-BETA-PHENYL-BETA-ALANYL-L-PROLYL-)2, PEPTIDE ISOLATED FROM ROCCELLA-CANARIENSIS [J].
BOHMANLI.G ;
RAGNARSS.U .
TETRAHEDRON, 1972, 28 (17) :4631-&
[5]   RHODOMYCINE .12. ANTIBIOTICA AUS ACTINOMYCETEN .56. KONFIGURATION UND KONFORMATION VON ALPHA-RHODOMYCINON BETA-RHODOMYCINON UND BETA-ISO-RHODOMYCINON [J].
BROCKMANN, H ;
NIEMEYER, J .
CHEMISCHE BERICHTE-RECUEIL, 1967, 100 (11) :3578-+
[6]  
GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1
[7]  
HENRY DW, 1976, ACS SYM SER, P15
[8]   TOTAL SYNTHESIS OF (+ OR -)-DAUNOMYCINONE AND (+ OR -)-CARMINOMYCINONE [J].
KENDE, AS ;
TSAY, YG ;
MILLS, JE .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1976, 98 (07) :1967-1969
[9]  
LIN AJ, 1976, ACS SYM SER, P71
[10]   BIOACTIVATION AS A MODEL FOR DRUG DESIGN BIOREDUCTIVE ALKYLATION [J].
MOORE, HW .
SCIENCE, 1977, 197 (4303) :527-532